Susquehanna International Group’s Purple Biotech PPBT Stock Holding History

Susquehanna International Group’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-154	Closed	-$43.1K	–	12749
2023 Q2	$43.1K	Buy	154 +8	+5%	+$2.87K	﹤0.01%	11394
2023 Q1	$51.4K	Sell	146 -542	-79%	-$203K	﹤0.01%	11693
2022 Q4	$190K	Buy	688 +191	+38%	+$73.3K	﹤0.01%	10212
2022 Q3	$202K	Buy	497 +223	+81%	+$104K	﹤0.01%	10824
2022 Q2	$131K	Buy	274 +30	+12%	+$18K	﹤0.01%	11200
2022 Q1	$194K	Sell	244 -89	-27%	-$57.4K	﹤0.01%	11271
2021 Q4	$259K	Sell	333 -599	-64%	-$510K	﹤0.01%	10838
2021 Q3	$850K	Sell	932 -381	-29%	-$369K	﹤0.01%	7985
2021 Q2	$1.28M	Buy	1,313 +759	+137%	+$697K	﹤0.01%	7069
2021 Q1	$458K	Buy	+554	New	+$517K	﹤0.01%	9687

Other funds holding PPBT

SmartHarvest Portfolios Poulsbo, Washington $240M AUM

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Susquehanna International Group's PPBT Position: Q1 2026 in Review

Susquehanna International Group increased its Purple Biotech (PPBT) stake by 14% in Q1 2026, buying an estimated $34.7K and bringing the position to 53,403 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #11539.

Susquehanna International Group first reported a position in PPBT in Q4 2017 and has held it in 12 quarters since. The position peaked at $309K in Q4 2025. 15 funds tracked by Wall St. Rank hold PPBT as of Q1 2026.

Susquehanna International Group held 53,403 shares of Purple Biotech worth $216K as of Q1 2026.
Susquehanna International Group bought 6,426 Purple Biotech shares in Q1 2026, an estimated $34.7K.
Purple Biotech made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11539 holding.
Susquehanna International Group first reported a position in Purple Biotech in Q4 2017 and has held it in 12 quarters since.
Susquehanna International Group's Purple Biotech position peaked at $309K in Q4 2025.
15 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.